Various medicinal products | Tenderlake

Various medicinal products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
01 September 2023
Closing Date:
28 September 2023
Location(s):
PL911 Miasto Warszawa (PL Poland/POLSKA)
Description:
Delivery of medicinal products, no. PN-169/23/TM

1. The object of the order is the delivery of medicinal products.

2. For a detailed description of the item of the order, see Annex 2 to SWZ (for all parts of the order).

Bicalutamidum

Bicalutamidum, described in detail in Annex 2 to the SWZ.

Sorafenibum

Sorafenibum, described in detail in Appendix 2 to the SWZ.

Trastuzumabum

Trastuzumabum, described in detail in Appendix No. 2 to the SWZ.

NIVOLUMABUM

Nivolumabum, described in detail in Annex 2 to the SWZ.

Pemetrexedum

Pemetreksedum, described in detail in Appendix 2 to the SWZ.

Lorlatinibum

Lorlatinibum, described in detail in Appendix 2 to the SWZ.

Crizotinib

Crizotinib, detailed in Appendix 2 to the SWZ.

Filgrastimum

Filgrastimum, described in detail in Annex 2 to the SWZ.

Abirateronum

Abirateronum, described in detail in Annex 2 to the SWZ.

Kabazazitaxel

Kabasitaxel, described in detail in Annex 2 to SWZ.

Tofacitinibum

Tofacitinibum, described in detail in Appendix No. 2 to the SWZ.

Capecitabinum

Capecitabinum, described in detail in Annex 2 to the SWZ.

Trastuzumabum

Trastuzumabum, described in detail in Appendix No. 2 to the SWZ.

Pazopanibum

Pazopanibum, described in detail in Appendix 2 to the SWZ.

Carfilzomibum

Carfilzomibum, described in detail in Appendix 2 to the SWZ.

Dostarlimabum

Dostarlimabum, described in detail in Appendix 2 to the SWZ.

Idelalisib

Idelalisib, described in detail in Appendix 2 to the SWZ.

Sotorasib

Sotorasib, described in detail in Appendix 2 to the SWZ.

Sirolimus

Sirolimus, described in detail in Annex 2 to the SWZ.

Erlotinibum

Erlotinibum, described in detail in Appendix 2 to the SWZ.

Bortezomibum

Bortezomibum, described in detail in Appendix 2 to the SWZ.

Erlotinibum

Erlotinibum, described in detail in Appendix 2 to the SWZ.

Fulvestrantum

Fulvestrantum, described in detail in Annex 2 to the SWZ.

Gefitynibum

Gefitinibum, described in detail in Annex 2 to the SWZ.

Pomalidomidum

Pomalidomidum, described in detail in Annex 2 to the SWZ.

Vinorelbinum

Vinorelbinum, described in detail in Annex 2 to the SWZ.

Sorafenibum

Sorafenibum, described in detail in Appendix 2 to the SWZ.

Download full details as .pdf
The Buyer:
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy
CPV Code(s):
33690000 - Various medicinal products